Ariela Holmer

577 total citations
13 papers, 342 citations indexed

About

Ariela Holmer is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Ariela Holmer has authored 13 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Ariela Holmer's work include Inflammatory Bowel Disease (12 papers), Microscopic Colitis (10 papers) and Eosinophilic Esophagitis (4 papers). Ariela Holmer is often cited by papers focused on Inflammatory Bowel Disease (12 papers), Microscopic Colitis (10 papers) and Eosinophilic Esophagitis (4 papers). Ariela Holmer collaborates with scholars based in United States, Italy and Canada. Ariela Holmer's co-authors include Siddharth Singh, William J. Sandborn, Jordan E. Axelrad, Adam S. Faye, Joseph Meserve, Vito Annese, Antonio Facciorusso, Parambir S. Dulai, Brigid S. Boland and Nghia Nguyen and has published in prestigious journals such as The American Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics and Clinical Gastroenterology and Hepatology.

In The Last Decade

Ariela Holmer

11 papers receiving 339 citations

Peers

Ariela Holmer
Ariela Holmer
Citations per year, relative to Ariela Holmer Ariela Holmer (= 1×) peers Panu Wetwittayakhlang

Countries citing papers authored by Ariela Holmer

Since Specialization
Citations

This map shows the geographic impact of Ariela Holmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariela Holmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariela Holmer more than expected).

Fields of papers citing papers by Ariela Holmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariela Holmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariela Holmer. The network helps show where Ariela Holmer may publish in the future.

Co-authorship network of co-authors of Ariela Holmer

This figure shows the co-authorship network connecting the top 25 collaborators of Ariela Holmer. A scholar is included among the top collaborators of Ariela Holmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariela Holmer. Ariela Holmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Rojanasopondist, Pakdee, Cristina Fernández, Alice Li, et al.. (2025). Safety and Efficacy of Ustekinumab and Vedolizumab Among Older Adults with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 71(2). 594–604.
2.
Hudesman, David, Feza H. Remzi, Jordan E. Axelrad, et al.. (2023). Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease. Therapeutic Advances in Gastroenterology. 16. 1108341207–1108341207.
3.
Faye, Adam S., Ariela Holmer, & Jordan E. Axelrad. (2022). Cancer in Inflammatory Bowel Disease. Gastroenterology Clinics of North America. 51(3). 649–666. 46 indexed citations
4.
Holmer, Ariela, Brigid S. Boland, Siddharth Singh, et al.. (2022). A Serum Biomarker Panel Can Accurately Identify Mucosal Ulcers in Patients With Crohn’s Disease. Inflammatory Bowel Diseases. 29(4). 555–562. 2 indexed citations
5.
Jangi, Sushrut, Ariela Holmer, Parambir S. Dulai, et al.. (2021). Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 20(4). e750–e760. 8 indexed citations
6.
Meserve, Joseph, Antonio Facciorusso, Ariela Holmer, et al.. (2020). Systematic review with meta‐analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre‐existing inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics. 53(3). 374–382. 59 indexed citations
7.
Battat, Robert, Amy Hemperly, Natalie Whitmire, et al.. (2020). Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 19(3). 511–518.e6. 34 indexed citations
8.
Holmer, Ariela, Brigid S. Boland, Siddharth Singh, et al.. (2020). P281 A serum biomarker panel can accurately identify the presence of mucosal ulcers in patients with Crohn’s disease. Journal of Crohn s and Colitis. 14(Supplement_1). S292–S293. 1 indexed citations
9.
Holmer, Ariela, Brigid S. Boland, Siddharth Singh, et al.. (2020). P302 Diagnostic accuracy of a serum-based biomarker panel for endoscopic activity in ulcerative colitis. Journal of Crohn s and Colitis. 14(Supplement_1). S304–S304. 2 indexed citations
10.
Holmer, Ariela, et al.. (2020). Effect of Lifestyle Factors on Outcomes in Patients With Inflammatory Bowel Diseases. The American Journal of Gastroenterology. 115(6). 832–840. 114 indexed citations
11.
Jangi, Sushrut, Ariela Holmer, Parambir S. Dulai, et al.. (2020). Risk of Relapse in Patients With Ulcerative Colitis With Persistent Endoscopic Healing: A Durable Treatment Endpoint. Journal of Crohn s and Colitis. 15(4). 567–574. 15 indexed citations
12.
Holmer, Ariela, Robert Battat, Parambir S. Dulai, et al.. (2020). Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn’s disease. Therapeutic Advances in Gastroenterology. 13. 3974160078–3974160078. 9 indexed citations
13.
Holmer, Ariela & Siddharth Singh. (2019). Overall and comparative safety of biologic and immunosuppressive therapy in inflammatory bowel diseases. Expert Review of Clinical Immunology. 15(9). 969–979. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026